IL33 and hyperinsulinemic hypoglycemia, familial, 4: This may reflect the existence of an alternative ILC- and mast cell-independent axis of IL-33-mediated immunity that compensates for the absent ILC and is visualised in these extreme models of effector cell deficiency.